

Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.658, 2012-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Should the UK NHS embrace disease management?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 252, 2000-01 ,pp. :


Should the UK NHS follow the US example going forward?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 493, 2005-01 ,pp. :


UK NHS should fund NICE-approved cancer therapies, says govt report
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 277, 2000-01 ,pp. :


PharmacoEconomics and Outcomes News, Vol. 1, Iss. 656, 2012-01 ,pp. :


Multiple Sclerosis in the UK: Service Use, Costs, Quality of Life and Disability
By McCrone Paul
PharmacoEconomics, Vol. 26, Iss. 10, 2008-01 ,pp. :